Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic stroke
Märit Jensen(Universität Hamburg), Götz Thomalla(Universität Hamburg), Alina Königsberg(Universität Hamburg), Jens Fiehler(Lyon 1 Université), Ian Ford, Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Keith W. Muir(University of Glasgow), Anke Wouters(Universität Hamburg), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Tae‐Hee Cho(Université Claude Bernard Lyon 1), Pascal Roy(Université Claude Bernard Lyon 1), Martin Ebinger(Universität Hamburg), Ivana Galinović(Universität Hamburg), Christian Gerloff(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Claus Z. Simonsen(Universität Hamburg), Matthias Endres(German Center for Neurodegenerative Diseases), Josep Puig(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1)
Cited by 7
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856